6640-- Thyroseq Testing

The Department of Veterans Affairs Network Contracting Office seeks molecular testing services utilizing the ThyroSeq next-generation sequencing assay to detect mutations in thyroid nodule fine needle aspiration samples. The solicitation requests these services be provided to the VA Greater Los Angeles Healthcare System located in Los Angeles, California. Responses for this combined synopsis/solicitation notice are due by April 1, 2022 at 9:00 AM Pacific Time and must be submitted electronically through beta.SAM.gov. The period of performance consists of one base year with four one-year options.

There is no set-aside designation for this requirement. The NAICS code is 541711 and PSC code is R499. The contractor must provide 120 ThyroSeq tests annually with a place of performance at 11301 Wilshire Blvd, Los Angeles, CA 90073. The estimated value is $0 as pricing details are listed as to be determined. Responses will be evaluated to ensure all qualifications, certifications, and salient characteristics are met to provide these molecular testing services to Veterans at the specified location.